Cargando…
What’s new in HIV dermatology?
HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600856/ https://www.ncbi.nlm.nih.gov/pubmed/31297183 http://dx.doi.org/10.12688/f1000research.16182.1 |
_version_ | 1783431196890365952 |
---|---|
author | Coates, Sarah J Leslie, Kieron S |
author_facet | Coates, Sarah J Leslie, Kieron S |
author_sort | Coates, Sarah J |
collection | PubMed |
description | HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity of persons living with HIV to develop difficult-to-control viral infections, chronic skin inflammation, and pruritus and—particularly as patients age—various types of skin cancers. Here, we summarize recent updates in the field of HIV dermatology and make recommendations to providers caring for these patients. |
format | Online Article Text |
id | pubmed-6600856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-66008562019-07-10 What’s new in HIV dermatology? Coates, Sarah J Leslie, Kieron S F1000Res Review HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity of persons living with HIV to develop difficult-to-control viral infections, chronic skin inflammation, and pruritus and—particularly as patients age—various types of skin cancers. Here, we summarize recent updates in the field of HIV dermatology and make recommendations to providers caring for these patients. F1000 Research Limited 2019-06-28 /pmc/articles/PMC6600856/ /pubmed/31297183 http://dx.doi.org/10.12688/f1000research.16182.1 Text en Copyright: © 2019 Coates SJ and Leslie KS http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Coates, Sarah J Leslie, Kieron S What’s new in HIV dermatology? |
title | What’s new in HIV dermatology? |
title_full | What’s new in HIV dermatology? |
title_fullStr | What’s new in HIV dermatology? |
title_full_unstemmed | What’s new in HIV dermatology? |
title_short | What’s new in HIV dermatology? |
title_sort | what’s new in hiv dermatology? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600856/ https://www.ncbi.nlm.nih.gov/pubmed/31297183 http://dx.doi.org/10.12688/f1000research.16182.1 |
work_keys_str_mv | AT coatessarahj whatsnewinhivdermatology AT lesliekierons whatsnewinhivdermatology |